CellaVision AB (publ) (CLVSF)
CLVSF Stock Price Chart
Explore CellaVision AB (publ) interactive price chart. Choose custom timeframes to analyze CLVSF price movements and trends.
CLVSF Company Profile
Discover essential business fundamentals and corporate details for CellaVision AB (publ) (CLVSF) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Devices
IPO Date
20 Aug 2013
Employees
228.00
Website
https://www.cellavision.comCEO
Simon Ostergaard
Description
CellaVision AB (publ) develops and sells digital solutions for blood and body fluids analysis in health care services sector in Sweden, Europe, the Middle East, Africa, the Americas, and the Asia Pacific. The company provides CellaVision DM1200 and CellaVision DM9600, which automatically capture digital images of cells from blood smears and body fluid preparations; and CellaVision DC-1, an analyzer. It also offers CellaVision Peripheral Blood Application that enables laboratories to automate, standardize, and simplify morphological examination of peripheral blood smears; CellaVision Advanced RBC Application, which enables to perform comprehensive examination of red blood cell morphology; CellaVision Body Fluid Application that enables laboratories to automate, standardize, and simplify morphological examination of body fluid preparations; and CellaVision Remote Review Software, which removes restrictive geographical constraints from the smear review process. In addition, the company provides CellaVision Server Software that creates a single streamlined workflow within one or multiple testing sites; CellaVision Dashboard, a tool designed to give an at-a-glance view of CellaVision analyzer and reviewer metrics; CellaVision Proficiency Software, a cloud-based software designed to help laboratory managers assess, monitor, and promote staff competency in the area of cell morphology; CellaVision CellAtlas, which combines a series of mini lectures with an extensive cell image library; and CellaVision VET that offers digital solutions for medical microscopy in the field of hematology. It sells its products to hospital and commercial laboratories. CellaVision AB (publ) was incorporated in 1994 and is headquartered in Lund, Sweden.
CLVSF Financial Timeline
Browse a chronological timeline of CellaVision AB (publ) corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 27 Apr 2026
Upcoming earnings on 5 Feb 2026
Upcoming earnings on 5 Nov 2025
Earnings released on 18 Jul 2025
EPS came in at $1.58 surpassing the estimated $0.17 by +812.24%, while revenue for the quarter reached $191.33M , beating expectations by +2.31%.
Earnings released on 29 Apr 2025
EPS came in at $1.74 surpassing the estimated $0.14 by +1.17K%, while revenue for the quarter reached $194.80M , beating expectations by +8.75%.
Earnings released on 6 Feb 2025
EPS came in at $1.72 surpassing the estimated $0.17 by +912.36%, while revenue for the quarter reached $186.69M , beating expectations by +924.22%.
Dividend declared on 6 Feb 2025
A dividend of $0.26 per share was announced, adjusted to $0.26. The dividend was paid on 13 May 2025.
Earnings released on 24 Oct 2024
EPS came in at $1.30 surpassing the estimated $0.17 by +680.31%, while revenue for the quarter reached $178.66M , beating expectations by +868.66%.
Earnings released on 19 Jul 2024
EPS came in at $1.62 surpassing the estimated $0.16 by +908.09%, while revenue for the quarter reached $187.79M , beating expectations by +956.07%.
Earnings released on 25 Apr 2024
EPS came in at $1.26 surpassing the estimated $0.14 by +792.35%, while revenue for the quarter reached $170.08M , beating expectations by +943.69%.
Earnings released on 7 Feb 2024
EPS came in at $2.11 surpassing the estimated $0.13 by +1.48K%, while revenue for the quarter reached $200.63M , beating expectations by +1.05K%.
Dividend declared on 7 Feb 2024
A dividend of $0.21 per share was announced, adjusted to $0.24. The dividend was paid on 13 May 2024.
Earnings released on 30 Sept 2023
EPS came in at $1.09 surpassing the estimated $0.12 by +794.18%, while revenue for the quarter reached $167.90M , beating expectations by +1.02K%.
Earnings released on 30 Jun 2023
EPS came in at $1.46 surpassing the estimated $0.12 by +1.16K%, while revenue for the quarter reached $169.67M , beating expectations by +1.05K%.
Earnings released on 31 Mar 2023
EPS came in at $0.81 surpassing the estimated $0.11 by +611.13%, while revenue for the quarter reached $139.10M , beating expectations by +841.68%.
Earnings released on 7 Feb 2023
EPS came in at $1.35 falling short of the estimated $1.54 by -12.34%, while revenue for the quarter reached $152.32M , beating expectations by +754.57%.
Dividend declared on 7 Feb 2023
A dividend of $0.22 per share was announced, adjusted to $0.24. The dividend was paid on 12 May 2023.
Earnings released on 26 Oct 2022
EPS came in at $0.44 falling short of the estimated $1.26 by -65.08%, while revenue for the quarter reached $141.03M , beating expectations by +901.73%.
Earnings released on 20 Jul 2022
EPS came in at $1.56 surpassing the estimated $1.49 by +4.70%, while revenue for the quarter reached $183.58M , beating expectations by +1.07K%.
Earnings released on 10 May 2022
EPS came in at $1.61 surpassing the estimated $1.37 by +17.52%, while revenue for the quarter reached $162.42M , beating expectations by +888.62%.
Dividend declared on 7 Feb 2022
A dividend of $0.20 per share was announced, adjusted to $0.21. The dividend was paid on 18 May 2022.
Earnings released on 4 Feb 2022
EPS came in at $1.67 surpassing the estimated $1.54 by +8.44%, while revenue for the quarter reached $164.16M .
Earnings released on 22 Oct 2021
EPS came in at $1.09 surpassing the estimated $1.08 by +0.93%, while revenue for the quarter reached $131.99M .
Earnings released on 20 Jul 2021
EPS came in at $1.30 surpassing the estimated $1.13 by +15.04%, while revenue for the quarter reached $135.45M .
Earnings released on 28 Apr 2021
EPS came in at $1.19 falling short of the estimated $1.21 by -1.65%, while revenue for the quarter reached $133.95M .
Dividend declared on 26 Mar 2021
A dividend of $0.09 per share was announced, adjusted to $0.08. The dividend was paid on 6 May 2021.
Earnings released on 4 Feb 2021
EPS came in at $1.20 falling short of the estimated $1.34 by -10.45%, while revenue for the quarter reached $130.99M .
Earnings released on 23 Oct 2020
EPS came in at $0.56 falling short of the estimated $1.00 by -44.00%, while revenue for the quarter reached $87.98M .
CLVSF Stock Performance
Access detailed CLVSF performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.